参考文献/References:
[1]Sharma D.Perioperative management of aneurysmalsubarachnoid hemorrhage[J].Anesthesiology,2020,133(6):1283-1305.[2]中国医师协会神经外科医师分会神经重症专家委员会,中华医学会神经外科学分会脑血管病学组,中国医师协会神经介入专业委员会,等.重症动脉瘤性蛛网膜下腔出血管理专家共识(2023)[J].中国脑血管病杂志,2023,20(2):126-144.[3]秦超,刘竞丽.蛛网膜下腔出血的诊断与治疗[J].中华神经科杂志,2020,53(10):814-818.[4]Chung DY,Abdalkader M,Nguyen TN.Aneurysmal Subarachnoid Hemorrhage[J].Neurol Clin,2021,39(2):419-442.[5]Hajizadeh Barfejani A,Rabinstein AA,Wijdicks EFM,et al.Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage[J].J Stroke Cerebrovasc Dis,2019,28(8):2155-2158.[6]陈洋,李林坤,陈升阳.动脉瘤性蛛网膜下腔出血患者术后并发医院感染的危险因素分析与相关模型构建[J].实用医院临床杂志,2021,18(5):191-195.[7]Rouanet C,Silva GS.Aneurysmal subarachnoid hemorrhage: current concepts and updates[J].Arq Neuropsiquiatr,2019,77(11):806-814.[8]Busl KM.Nosocomial infections in the neurointensive care unit[J].Neurol Clin,2017,35(4):785-807.[9]余果,孙代艳,李源,等.我国医院感染的经济损失研究[J].医学与社会,2016,29(7):70-72.[10]Giraldi G,Montesano M,Sandorfi F,et al.Excess length of hospital stay due to healthcare acquired infections: methodologies evaluation[J].Ann Ig,2019,31(5):507-516.[11]Benenson S,Cohen MJ,Schwartz C,et al.Is it financially beneficial for hospitals to prevent nosocomial infections?[J].BMC Health Serv Res,2020,20(1):653.[12]Kaier K,Wolkewitz M,Hehn P,et al.The impact of hospital-acquired infections on the patient-level reimbursement-cost relationship in a DRG-based hospital payment system[J].Int J Health Econ Manag,2020,20(1):1-11.[13]Liu Y,Xiao W,Wang S,et al.Evaluating the direct economic burden of health care-associated infections among patients with colorectal cancer surgery in China[J].Am J Infect Control,2018,46(1):34-38.[14]刘雪燕,王光鹏,姚雪,等.神经外科患者医院感染经济负担和住院时间分析[J].山东大学学报(医学版),2021,59(10):87-93.[15]何双英,唐红宇,王爱民.动脉瘤性蛛网膜下腔出血患者医院感染危险因素[J].中国感染控制杂志,2016,15(6):408-411.[16]Laban KG,Rinkel GJ,Vergouwen MD.Nosocomial infections after aneurysmal subarachnoid hemorrhage: time course and causative pathogens[J].Int J Stroke,2015,10(5):763-766.[17]Kang SH,Cheong HJ,Song JY,et al.Analysis of risk factors for severe acute respiratory infection and pneumonia and among adult patients with acute respiratory illness during 2011-2014 influenza seasons in Korea[J].Infect Chemother,2016,48(4):294-301.[18]Dick AW,Perencevich EN,Pogorzelska-Maziarz M,et al.A decade of investment in infection prevention: a cost-effectiveness analysis[J].Am J Infect Control,2015,43(1):4-9.[19]Shi ZH,Xu M,Wang YZ,et al.Post-craniotomy intracranial infection in patients with brain tumors: a retrospective analysis of 5723 consecutive patients[J].Br J Neurosurg,2017,31(1):5-9.[20]刘卫平,邢慧敏,郭天慧,等.内蒙古自治区某三级医院住院患者常见医院感染的直接经济损失[J].中国感染控制杂志,2019,18(12):1099-1105.
相似文献/References:
[1]石 油,朱 继.低钠血症及血钠波动对动脉瘤性蛛网膜下腔出血患者预后的影响研究[J].医学信息,2018,31(03):73.[doi:10.3969/j.issn.1006-1959.2018.03.023]
SHI You,ZHU Ji.Effect of Natriuremia and Blood Sodium Fluctuation on Prognosis of Patients with Aneurysm Subarachnoid Hemorrhage[J].Journal of Medical Information,2018,31(09):73.[doi:10.3969/j.issn.1006-1959.2018.03.023]
[2]王雪梅,区 清.某二级医院医院感染现患率调查分析与对策[J].医学信息,2018,31(05):120.[doi:10.3969/j.issn.1006-1959.2018.05.042]
WANG Xue-mei,QU Qing.Investigation and Analysis of Nosocomial Infection Rate in a Level-II Hospital and its Countermeasures[J].Journal of Medical Information,2018,31(09):120.[doi:10.3969/j.issn.1006-1959.2018.05.042]
[3]周 刚.右美托咪定改善全麻苏醒期患者血液动力学及
医院感染的疗效观察[J].医学信息,2018,31(12):128.[doi:10.3969/j.issn.1006-1959.2018.12.039]
ZHOU Gang.Effect of Dexmedetomidine on Improving Hemodynamics and Nosocomial Infection in Patients with General Anesthesia[J].Journal of Medical Information,2018,31(09):128.[doi:10.3969/j.issn.1006-1959.2018.12.039]
[4]章 琦,郑雪梅,李宝珍,等.医务人员医院感染防控知信行现状及其培训需求调查分析[J].医学信息,2022,35(13):168.[doi:10.3969/j.issn.1006-1959.2022.13.042]
ZHANG Qi,ZHENG Xue-mei,LI Bao-zhen,et al.Investigation and Analysis on KAP Status and Training Needs of Hospital Infection Prevention and Control Among Medical Staff[J].Journal of Medical Information,2022,35(09):168.[doi:10.3969/j.issn.1006-1959.2022.13.042]
[5]周 蓉.神经外科颅脑手术患者医院感染危险因素分析[J].医学信息,2019,32(07):104.[doi:10.3969/j.issn.1006-1959.2019.07.030]
ZHOU Rong.Analysis of Risk Factors for Nosocomial Infection in Patients with Neurosurgical Brain Surgery[J].Journal of Medical Information,2019,32(09):104.[doi:10.3969/j.issn.1006-1959.2019.07.030]
[6]刘文军,张东湖,黄 锋,等.基于CDR的医院感染闭环管理应用[J].医学信息,2019,32(08):17.[doi:10.3969/j.issn.1006-1959.2019.08.005]
LIU Wen-jun,ZHANG Dong-hu,HUANG Feng,et al.CDR-based Hospital Infection Closed-loop Management Application[J].Journal of Medical Information,2019,32(09):17.[doi:10.3969/j.issn.1006-1959.2019.08.005]
[7]顾万娟,李 亮,张 振,等.多重耐药菌的临床分布与耐药性分析[J].医学信息,2019,32(15):116.[doi:10.3969/j.issn.1006-1959.2019.15.038]
GU Wan-juan,LI Liang,ZHANG Zhen,et al.Analysis of Clinical Distribution and Drug Resistance of Multi-drug Resistant Bacteria[J].Journal of Medical Information,2019,32(09):116.[doi:10.3969/j.issn.1006-1959.2019.15.038]
[8]吴毅萍,余 虹,沈菊艳.精细护理路径管理在消化内镜室医院感染控制中的应用效果[J].医学信息,2022,35(14):184.[doi:10.3969/j.issn.1006-1959.2022.14.048]
WU Yi-ping,YU Hong,SHEN Ju-yan.Application Effect of Refined Nursing Pathway Management in Nosocomial Infection Control in Digestive Endoscopy Room[J].Journal of Medical Information,2022,35(09):184.[doi:10.3969/j.issn.1006-1959.2022.14.048]
[9]张 楠,白昊坤,赵 怀,等.某综合医院住院患者医院感染现患率调查[J].医学信息,2019,32(17):126.[doi:10.3969/j.issn.1006-1959.2019.17.041]
ZHANG Nan,BAI Hao-kun,ZHAO Huai,et al.Investigation on the Prevalence of Nosocomial Infection in Hospitalized Patients in A General Hospital[J].Journal of Medical Information,2019,32(09):126.[doi:10.3969/j.issn.1006-1959.2019.17.041]
[10]杨 萍,袁华兵.三级综合医院多重耐药菌特点及直接经济负担分析[J].医学信息,2022,35(16):132.[doi:10.3969/j.issn.1006-1959.2022.16.033]
YANG Ping,YUAN Hua-bing.Analysis of Characteristics and Direct Economic Burden of Multi-drug Resistant Organisms in Tertiary General Hospitals[J].Journal of Medical Information,2022,35(09):132.[doi:10.3969/j.issn.1006-1959.2022.16.033]